Intracellular delivery of nanoparticles of an antiasthmatic drug

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 217-223

  Surti, Naazneen ^a   Naik, Sachin ^a   Bagchi, Tamishraha ^a   Dwarkanath, B S ^b   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Intracellular levels; L lactic co glycolic) acid; Mometasone furoate; Nanoparticles; Poly(D; L; Sustained delivery; Wheat germ agglutinin

Indexed keywords

ANTIASTHMATIC AGENT; CYANAMIDE; MOMETASONE FUROATE; NANOPARTICLE; POLYGLACTIN; SOLVENT; WHEAT GERM AGGLUTININ; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PREGNANE DERIVATIVE;

AREA UNDER THE CURVE; ARTICLE; CELL INTERACTION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; DRY POWDER; EMULSION; ENCAPSULATION; EPITHELIUM CELL; EVAPORATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; POWDER INHALER; SUSTAINED RELEASE FORMULATION; ZETA POTENTIAL; CELL LINE; CHEMISTRY; DIFFUSION; DRUG SCREENING; EVALUATION; LUNG ALVEOLUS; MATERIALS TESTING; METABOLISM; METHODOLOGY;

ANTI-ASTHMATIC AGENTS; CELL LINE; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; HUMANS; LACTIC ACID; MATERIALS TESTING; NANOPARTICLES; POLYGLYCOLIC ACID; PREGNADIENEDIOLS; PULMONARY ALVEOLI; WHEAT GERM AGGLUTININS;

EID: 44849138911     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9036-x     Document Type: Article

References (20)

1. H. Suh, B. Jeong, R. Rathi, and S. W. Kim. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly (ethylene oxide)-poly (lactide/glycolide) nanospheres. J. Biomed. Mater. Res. 42:331-338 (1998).
2. J. M. Anderson, and M. S. Shive. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev. 28:5-24 (1997).
3. J. Panyam, and V. Labhasetwar. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 553:(3)29-347 (2003).
4. J. Panyam, W. Z. Zhou, S. Prabha, S. K. Sahoo, and V. Labhasetwar. Rapid endo-lysomal escape of poly (d, l- lactide-co-glycolide) nanoparticles: implication for drug and gene delivery. FASEB J. 16:1217-1226 (2002).
5. I. J. Goldstein, and C. E. Hayes. The lectins: Carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem. 35:127-340 (1978).
6. M. A. Clark, B. H. Hirst, and M. A. Jepson. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 43(2-3):207-223 (2000).
7. R. Abu-Dahab, U. F. Schafer, and C. M. Lehr. Lectin-functionalized liposomes for pulmonary drug delivery: Effect of nebulization on stability and bioadhesion. Eur. J. Pharm. Sci. 14(1):37-46 (2001).
8. C. M. Lehr. Lectin-mediated drug delivery: The second generation of bioadhesives. J. Control Release. 65(1-2):19-29 (2000).
9. C. Crocker, Chang Yi Zhou, A. Bewtra, W. Kreutner, and R. Townley. Glucocorticosteroids inhibit leukotriene production. Ann. Allergy Asthma Immunol. 78:497-505 (1997).
10. D. J. Margolskee. Clinical experience with MK-571: A potent and specific LTD4 receptor antagonist. Ann. N. Y. Acad. Sci. 629:148-156 (1991).
11. N. Chanarin, and S. L. Johnston. Leukotrienes as a target in asthma therapy. Drugs. 47(1):12-24 (1994).
12. D. P. Skoner, L. Lee, W. J. Doyle et al. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann. Allergy. 65:206-210 (1990).
13. B. E. Barton, J. P. Jakway, S. R. Smith, and M. I. Siegel. Cytokine inhibition by a novel steroid, Mometasone furoate. Immunopharmacol. Immunotoxicol. 13(3):251-261 (1991).
14. U. B. Kompella, N. Bandi, and S. P. Ayalasomayajula. Poly (lactic acid) nanoparticles for sustained release of budesonide. Drug Delivery Technology. 1:29-35 (2001).
15. Z. Grabarek, and J. Gergely. Zero-length cross-linking procedure with the use of active esters. Anal. Biochem. 185:131-135 (1990).
16. S. Naazneen, S. Naik, T. Bagchi, and A. Misra. Assessment of in-vitro antiproliferative activity after intracellular drug delivery from wheat germ agglutinin-conjugated budesonide nanoparticles. J. Biomed. Nanotechnol. 3:61-67 (2007).
17. M. Nikolova, I. Savova, and M. Marinov. An optimized method for investigation of the yeast viability by means of fluorescent microscopy. J. Cult. Collect. 3(1):66-71 (2002).
18. M. Wirth, A. Fuchs, M. Wolf, B. Ertl, and F. Gabor. Lectin mediated drug targeting: Preparation, binding characteristics and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharm. Res. 15:1031-1037 (1998).
19. K. D. Wittrup, and J. E. Bailey. Comments on a segregated model of recombinant cultures. Biotechnol. Bioengineering. 35:525-532 (1990).
20. J. A. Cidlowski, K. L. King, R. B. Evans-Storms, J. W. Montague, C. D. Bortner, and F. M. Hughes Jr. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog. Horm. Res. 51:457-490 (1996).